You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-HBsAg

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

Not yet recruiting
  • Chronic Hepatitis b
  • +2 more
  • Anti-PD-1 antibody
  • +2 more
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023

Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

Not yet recruiting
  • Chronic Hepatitis b
  • Anti-PD-1 Antibody
  • Anti-PD-1 antibody
  • NAs
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 3, 2023

HBsAg Declined Patients Follow-up Study

Not yet recruiting
  • Hepatitis B
  • Hepatitis B, Chronic
    • (no location specified)
    Jul 28, 2023

    Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • Hong Kong, Hong Kong SAR, Hong Kong
      Humanity & Health Research Centre
    Mar 16, 2022

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Edegem, Belgium
    • +12 more
    Jan 17, 2023

    Hepatitis B Trial in Worldwide (GSK3228836, Nucleos(t)ide therapy)

    Recruiting
    • Hepatitis B
    • Boston, Massachusetts
    • +3 more
    Aug 24, 2022

    Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

    Recruiting
    • Hepatitis B
    • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
    • +4 more
    • Cambridge, United Kingdom
      GSK Investigational Site
    Jan 12, 2023

    Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

    Recruiting
    • Hepatitis B
    • HIV Infections
    • San Diego, California
    • +35 more
    Jan 31, 2023

    Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)

    Completed
    • Vaccine-Preventable Diseases
    • Hepatitis B
    • CVI-HBV-002
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      CHA University Bundang Medical Center
    Nov 19, 2023

    Chronic Hepatitis B Trial (Imdusiran (AB-729))

    Not yet recruiting
    • Chronic Hepatitis B
    • Imdusiran (AB-729)
    • (no location specified)
    Nov 30, 2023

    Chronic Hepatitis B Trial in Hong Kong (Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV

    Recruiting
    • Chronic Hepatitis B
    • Stop current treatment (anti-HBV neucleos(t)ides)
    • Keep current treatment (anti-HBV neucleos(t)ides)
    • Hong Kong, Hong Kong SAR, Hong Kong
      Humanity & Health Research Centre
    Mar 16, 2022

    Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

    Recruiting
    • Chronic HBV Infection
    • Peginterferon alfa-2b combined and ETV
    • Shenzhen, China
      Shenzhen Third People Hospital
    Mar 19, 2023

    Hepatitis B Reactivation Trial in Chiayi City, Tainan, Yun-Lin (Tenofovir alafenamide)

    Recruiting
    • Hepatitis B Reactivation
    • Tenofovir alafenamide
    • Chiayi City, Taiwan
    • +4 more
    Apr 26, 2022

    Chronic Hepatitis B Infection, Chronic Hepatitis D Infection Trial in Taipei City, Taipei city, Taoyuan city (P1101 + Nivolumab

    Recruiting
    • Chronic Hepatitis B Infection
    • Chronic Hepatitis D Infection
    • P1101 + Nivolumab + Entecavir
    • Taipei City, Taiwan
    • +3 more
    Sep 15, 2021

    Hepatitis B Reactivations in Patients Affected by Chronic

    Completed
    • Chronic Lymphocytic Leukemia
    • Cona, Ferrara, Italy
    • +22 more
    May 11, 2022

    Hepatitis B Trial in Bandung (Recombinant Hepatitis B (Bio Farma) Vaccine, Recombinant Hepatitis B (Bio Farma) Vaccine®)

    Completed
    • Hepatitis B
    • Recombinant Hepatitis B (Bio Farma) Vaccine
    • Recombinant Hepatitis B (Bio Farma) Vaccine®
    • Bandung, West Java, Indonesia
      Hasan Sadikin Hospital
    Jul 29, 2022

    Hepatitis B Trial in Worldwide (JNJ-56136379, Placebo, NA (ETV or TDF))

    Completed
    Has Results
    • Hepatitis B
    • Bakersfield, California
    • +75 more
    Oct 24, 2022

    Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

    Not yet recruiting
    • Hepatitis b Virus
    • HepB mAb19
    • Sterile Saline
    • New York, New York
    • +1 more
    May 12, 2023

    Burden of Hepatitis D Virus Infection in China Through

    Not yet recruiting
    • Hepatitis D
    • +3 more
    • HDV-Ab (IgG), HDV-RNA, RNA genotype
    • (no location specified)
    Nov 1, 2022

    HBV, Inflammatory Arthritis Trial (Tenofovir alafenamide)

    Not yet recruiting
    • HBV
    • Inflammatory Arthritis
    • Tenofovir alafenamide
    • (no location specified)
    Aug 5, 2021

    Healthy Trial in United States (Alinity s HBsAg and Alinity s HBsAg Confirmatory Assay, Alinity s HTLV I/II Assay, Alinity s

    Completed
    Has Results
    • Healthy
    • Alinity s HBsAg and Alinity s HBsAg Confirmatory Assay
    • +5 more
    • Boca Raton, Florida
    • +4 more
    Sep 17, 2019

    Hepatitis B, C and D and HIV Along Maroni River Bordering French

    Completed
    • Hepatitis B
    • +5 more
    • Questionnaire
    • +6 more
    • Cayenne, French Guiana
      General Hospital of Cayenne
    Aug 10, 2021

    Hepatitis B, Lymphoma, Non-Hodgkin Trial in Toronto (Tenofovir disoproxil, Placebo Oral Tablet)

    Unknown status
    • Hepatitis B
    • +2 more
    • Tenofovir disoproxil
    • Placebo Oral Tablet
    • Toronto, Ontario, Canada
    • +1 more
    Dec 10, 2019

    Immunogenicity, Safety Trial in Bandung (Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered))

    Completed
    • Immunogenicity
    • Safety
    • Recombinant Hepatitis B + DTP-HB-Hib
    • Hep B + Pentabio (registered)
    • Bandung, West Java, Indonesia
    • +2 more
    Jan 13, 2022